About
Cannabinoid technologies
Areas of Focus
Categories
Cannabis & MarijuanaMiddle East
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
331
By Phase
PHASE2: 4NA: 1
By Status
UNKNOWN: 2NOT_YET_RECRUITING: 1RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05126888Lead Sponsor
SCI-110 in the Treatment of Tourette Syndrome
PHASE2Not yet recruiting
164 participants
Started: Aug 31, 2025 · Completed: Feb 28, 2026
NCT05182697Lead Sponsor
SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)
NARecruiting
60 participants
Started: Feb 21, 2024 · Completed: Jun 30, 2026
NCT03651726Lead Sponsor
A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome
PHASE2Unknown
60 participants
Started: Aug 31, 2018 · Completed: Nov 30, 2019
NCT03646552Lead Sponsor
A Study to Examine the Efficacy of a Therapeutic THX-110 for Obstructive Sleep Apnea
PHASE2Unknown
30 participants
Started: Jun 4, 2018 · Completed: Apr 30, 2019
NCT03066193Collaborator
Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome
PHASE2Completed
17 participants
Started: Feb 1, 2017 · Completed: Jun 28, 2018
Locations (1)
Headquarters
Givatayim, Israel
Map
Loading map...